Bioscience Animal Health PCL

Bioscience Animal Health PCL ROCE

The Return on Capital Employed (ROCE) of Bioscience Animal Health PCL (BIS.BK) as of Nov 18, 2026 is 2.49 %. In the previous year, Return on Capital Employed (ROCE) was 11.65 % — a change of -78.64% (lower).

ROCE

2.49 %

YoY

-78.64%

Last updated:

In 2025, Bioscience Animal Health PCL's return on capital employed (ROCE) was 2.49 %, a -78.64% increase from the 11.65 % ROCE in the previous year.

The Bioscience Animal Health PCL ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
9.32 THB
Jan 1, 2019
30.81 THB
Jan 1, 2020
37.04 THB
Jan 1, 2021
36.07 THB
Jan 1, 2022
10.67 THB
Jan 1, 2023
8.64 THB
Jan 1, 2024
11.65 THB
Jan 1, 2025
2.49 THB
The Bioscience Animal Health PCL ROCE history
YEARROCEYoY
2.49 %-78.64%
11.65 %+34.92%
8.64 %-19.07%
10.67 %-70.41%
36.07 %-2.63%
37.04 %+20.24%
30.81 %+230.60%
9.32 %-48.38%
18.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioscience Animal Health PCL Stock analysis

What does Bioscience Animal Health PCL do? Bioscience Animal Health PCL manufactures, imports, and distributes medical supplies, tools, equipment, and products for livestock and pets. The company focuses on specialist veterinarian-selected products to improve animal health, offering antibiotics like Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin, as well as injections such as Zuprevo, Nuflor, Ceva, and Enzaprost. It also provides BiSMiX B-Series, BiSMiX SD Series, mold inhibitors, water-soluble products, and vaccines. Services include farm advisory, disease prevention, serological diagnosis, biosafety management, feed analysis, and personnel training programs. The company's revenue comes from selling medical supplies, equipment, and products to livestock and pet care providers. Key buyers include farms, veterinary clinics, and animal health facilities that require antibiotics, injections, and specialized animal health solutions. The firm targets segments focused on livestock and pet health through its product portfolio and advisory services, emphasizing veterinarian-approved solutions for improved animal welfare and farm efficiency. Bioscience Animal Health PCL's product lines are designed to address specific veterinary needs, with brands like BiSMiX B-Series and BiSMiX SD Series being central to its offerings. The company leverages its distribution network to supply both direct and indirect clients across the animal health sector, ensuring access to critical veterinary products and services that support disease prevention and farm management. Bioscience Animal Health PCL is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Bioscience Animal Health PCL's Return on Capital Employed (ROCE)

Bioscience Animal Health PCL's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Bioscience Animal Health PCL's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Bioscience Animal Health PCL's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Bioscience Animal Health PCL’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Bioscience Animal Health PCL stock

Return on Capital Employed (ROCE) of Bioscience Animal Health PCL is 2.49 % in 2025.

Return on Capital Employed (ROCE) of Bioscience Animal Health PCL changed from 11.65 % to 2.49 %, representing a -78.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Bioscience Animal Health PCL since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Bioscience Animal Health PCL with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Bioscience Animal Health PCL

All Key Metrics — Bioscience Animal Health PCL